Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

OBJECTIVE: To assess the efficacy/safety of tofacitinib in adult patients with active ankylosing spondylitis (AS). METHODS: This phase III, randomised, double-blind, placebo-controlled study enrolled patients aged ≥18 years diagnosed with active AS, meeting the modified New York criteria, with centr...

Descripción completa

Detalles Bibliográficos
Autores principales: Deodhar, Atul, Sliwinska-Stanczyk, Paula, Xu, Huji, Baraliakos, Xenofon, Gensler, Lianne S, Fleishaker, Dona, Wang, Lisy, Wu, Joseph, Menon, Sujatha, Wang, Cunshan, Dina, Oluwaseyi, Fallon, Lara, Kanik, Keith S, van der Heijde, Désirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292568/
https://www.ncbi.nlm.nih.gov/pubmed/33906853
http://dx.doi.org/10.1136/annrheumdis-2020-219601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292568/
https://www.ncbi.nlm.nih.gov/pubmed/33906853
http://dx.doi.org/10.1136/annrheumdis-2020-219601

Ejemplares similares